← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Archer Pharmaceuticals, Inc.
Sarasota, FL
$1,886,317
Total funding
2
Grants
Funding over time
peak $812.4K · FY2011–21$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,886,317 · 2
By mechanism
R42$1,736,317 · 1
R43$150,000 · 1
Investigators at Archer Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of Spleen Tyrosine Kinase (SYK) negative allosteric modifiers for therapeutic intervention in Alzheimer's disease.$812,379
R42 · FY2020 · AG
Development of Spleen Tyrosine Kinase (SYK) negative allosteric modifiers for therapeutic intervention in Alzheimer's disease.$699,018
R42 · FY2021 · AG
Development of Spleen Tyrosine Kinase (SYK) negative allosteric modifiers for therapeutic intervention in Alzheimer's disease.$224,920
R42 · FY2018 · AG
Pre-clinical Development of a Therapeutic for Alzheimer's Disease$150,000
R43 · FY2011 · AG